Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by DJDawgon Mar 28, 2023 1:18pm
276 Views
Post# 35364953

catalysts

catalysts
Major catalysts that we are waiting on:
- FDA BTD
- announcement of some relationship that provides some more cash to keep rolling and reduce the fear of another PP at 0.25 price point.
- announcement re IND application for a phase 1 test of Ruvidar in GBM and NSCLC

Small scale catalysts
- RDW taking over and doing some PR that makes new buyers aware of the stock. This would move price since volume of sellers is actuallly low (as a proportion of shares outstanding)
- Vaccine announcement. I highly doubt this will do much but I'll add to this list.
- some announcement regarding insider buying again that show ongoing optimism by people who have access to data that know one else has.

IMO

<< Previous
Bullboard Posts
Next >>